SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Tempus AI Extends AstraZeneca Partnership With $200 Million Commitment

Tempus AI amended its master services agreement with AstraZeneca, extending it through December 31, 2031. AstraZeneca committed to $200 million in fees over five years, including a minimum of $32 million per calendar year.

TEM

Tempus AI amended its Master Services Agreement with AstraZeneca, creating a new five-year financial commitment period and extending the agreement through December 31, 2031. AstraZeneca committed to $200 million in fees over the term, including a minimum of $32 million per calendar year. If the agg…

Related stories